Advancing the management of acute intermediate-high-risk pulmonary embolism: The enduring legacy of Professor Guy Meyer
Open Access
- 6 September 2024
- journal article
- review article
- Published by Elsevier in La Presse Médicale
- Vol. 53 (3) , 104248
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Drivers and recent trends of hospitalisation costs related to acute pulmonary embolismClinical Research in Cardiology, 2024
- Pulmonary embolism response team (PERT) implementation and its clinical value across countries: a scoping review and meta-analysisClinical Research in Cardiology, 2022
- Pulmonary Embolism Hospitalization, Readmission, and Mortality Rates in US Older Adults, 1999-2015JAMA, 2019
- Changes in treatment and outcomes after creation of a pulmonary embolism response team (PERT), a 10-year analysisJournal of Thrombosis and Thrombolysis, 2018
- Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusionThe Lancet, 1993
- PAIMS 2: Alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2JACC, 1992
- Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism: A European multicenter double-blind trialJACC, 1992
- Echocardiographic findings in patients with proved pulmonary embolismAmerican Heart Journal, 1986
- Urokinase-Streptokinase Embolism TrialJAMA, 1974
- Urokinase Pulmonary Embolism TrialJAMA, 1970